Dimension Therapeutics, Inc. (“Dimension” or the “Company”), a rare disease company advancing novel treatments for diverse genetic disorders of the liver based upon an AAV gene therapy platform, today announced that Annalisa Jenkins, MBBS, MRCP, Chief Executive Officer, will present a corporate overview at the 17th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2015 at 10:15 a.m. Eastern Time at the Waldorf Astoria in New York City.
Help employers find you! Check out all the jobs and post your resume.
